Papaverine Enhances the Oncolytic Effects of Newcastle Disease Virus on Breast Cancer In Vitro and In Vivo

Breast cancer is a lethal disease in females worldwide and needs effective treatment. Targeting cancer cells with selective and safe treatment seems like the best choice, as most chemotherapeutic drugs act unselectively. Papaverine showed promising antitumor activity with a high safety profile and i...

Full description

Saved in:
Bibliographic Details
Main Authors: Sura Akram, Ahmed Majeed Al-Shammari, Hayder B. Sahib, Majid Sakhi Jabir
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:International Journal of Microbiology
Online Access:http://dx.doi.org/10.1155/2023/3324247
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832559613029908480
author Sura Akram
Ahmed Majeed Al-Shammari
Hayder B. Sahib
Majid Sakhi Jabir
author_facet Sura Akram
Ahmed Majeed Al-Shammari
Hayder B. Sahib
Majid Sakhi Jabir
author_sort Sura Akram
collection DOAJ
description Breast cancer is a lethal disease in females worldwide and needs effective treatment. Targeting cancer cells with selective and safe treatment seems like the best choice, as most chemotherapeutic drugs act unselectively. Papaverine showed promising antitumor activity with a high safety profile and increased blood flow through vasodilation. At the same time, it was widely noticed that virotherapy using the Newcastle disease virus proved to be safe and selective against a broad range of cancer cells. Furthermore, combination therapy is favorable, as it attacks cancer cells with multiple mechanisms and enhances virus entrance into the tumor mass, overcoming cancer cells’ resistance to therapy. Therefore, we aimed at assessing the novel combination of the AMHA1 strain of Newcastle disease virus (NDV) and nonnarcotic opium alkaloid (papaverine) against breast cancer models in vitro and in vivo. Methods. In vitro experiments used two human breast cancer cell lines and one normal cell line and were treated with NDV, papaverine, and a combination. The study included a cell viability MTT assay, morphological analysis, and apoptosis detection. Animal experiments used the AN3 mouse mammary adenocarcinoma tumor model. Evaluation of the antitumor activity included growth inhibition measurement; the immunohistochemistry assay measured caspase protein expression. Finally, a semiquantitative microarray assay was used to screen changes in apoptotic proteins. In vitro, results showed that the combination therapy induces synergistic cytotoxicity and apoptosis against cancer cells with a negligible cytotoxic effect on normal cells. In vivo, combination treatment induced a significant antitumor effect with an obvious regression in tumor size and a remarkable and significant expression of caspase-3, caspase-8, and caspase-9 compared to monotherapies. Microarray analysis shows higher apoptosis protein levels in the combination therapy group. In conclusion, this study demonstrated the role of papaverine in enhancing the antitumor activity of NDV, suggesting a promising strategy for breast cancer therapy through nonchemotherapeutic drugs.
format Article
id doaj-art-31bc936d9bef4b95a1e2319007363d01
institution Kabale University
issn 1687-9198
language English
publishDate 2023-01-01
publisher Wiley
record_format Article
series International Journal of Microbiology
spelling doaj-art-31bc936d9bef4b95a1e2319007363d012025-02-03T01:29:33ZengWileyInternational Journal of Microbiology1687-91982023-01-01202310.1155/2023/3324247Papaverine Enhances the Oncolytic Effects of Newcastle Disease Virus on Breast Cancer In Vitro and In VivoSura Akram0Ahmed Majeed Al-Shammari1Hayder B. Sahib2Majid Sakhi Jabir3Department of PharmacologyExperimental TherapyDepartment of PharmacologyDepartment of Applied ScienceBreast cancer is a lethal disease in females worldwide and needs effective treatment. Targeting cancer cells with selective and safe treatment seems like the best choice, as most chemotherapeutic drugs act unselectively. Papaverine showed promising antitumor activity with a high safety profile and increased blood flow through vasodilation. At the same time, it was widely noticed that virotherapy using the Newcastle disease virus proved to be safe and selective against a broad range of cancer cells. Furthermore, combination therapy is favorable, as it attacks cancer cells with multiple mechanisms and enhances virus entrance into the tumor mass, overcoming cancer cells’ resistance to therapy. Therefore, we aimed at assessing the novel combination of the AMHA1 strain of Newcastle disease virus (NDV) and nonnarcotic opium alkaloid (papaverine) against breast cancer models in vitro and in vivo. Methods. In vitro experiments used two human breast cancer cell lines and one normal cell line and were treated with NDV, papaverine, and a combination. The study included a cell viability MTT assay, morphological analysis, and apoptosis detection. Animal experiments used the AN3 mouse mammary adenocarcinoma tumor model. Evaluation of the antitumor activity included growth inhibition measurement; the immunohistochemistry assay measured caspase protein expression. Finally, a semiquantitative microarray assay was used to screen changes in apoptotic proteins. In vitro, results showed that the combination therapy induces synergistic cytotoxicity and apoptosis against cancer cells with a negligible cytotoxic effect on normal cells. In vivo, combination treatment induced a significant antitumor effect with an obvious regression in tumor size and a remarkable and significant expression of caspase-3, caspase-8, and caspase-9 compared to monotherapies. Microarray analysis shows higher apoptosis protein levels in the combination therapy group. In conclusion, this study demonstrated the role of papaverine in enhancing the antitumor activity of NDV, suggesting a promising strategy for breast cancer therapy through nonchemotherapeutic drugs.http://dx.doi.org/10.1155/2023/3324247
spellingShingle Sura Akram
Ahmed Majeed Al-Shammari
Hayder B. Sahib
Majid Sakhi Jabir
Papaverine Enhances the Oncolytic Effects of Newcastle Disease Virus on Breast Cancer In Vitro and In Vivo
International Journal of Microbiology
title Papaverine Enhances the Oncolytic Effects of Newcastle Disease Virus on Breast Cancer In Vitro and In Vivo
title_full Papaverine Enhances the Oncolytic Effects of Newcastle Disease Virus on Breast Cancer In Vitro and In Vivo
title_fullStr Papaverine Enhances the Oncolytic Effects of Newcastle Disease Virus on Breast Cancer In Vitro and In Vivo
title_full_unstemmed Papaverine Enhances the Oncolytic Effects of Newcastle Disease Virus on Breast Cancer In Vitro and In Vivo
title_short Papaverine Enhances the Oncolytic Effects of Newcastle Disease Virus on Breast Cancer In Vitro and In Vivo
title_sort papaverine enhances the oncolytic effects of newcastle disease virus on breast cancer in vitro and in vivo
url http://dx.doi.org/10.1155/2023/3324247
work_keys_str_mv AT suraakram papaverineenhancestheoncolyticeffectsofnewcastlediseasevirusonbreastcancerinvitroandinvivo
AT ahmedmajeedalshammari papaverineenhancestheoncolyticeffectsofnewcastlediseasevirusonbreastcancerinvitroandinvivo
AT hayderbsahib papaverineenhancestheoncolyticeffectsofnewcastlediseasevirusonbreastcancerinvitroandinvivo
AT majidsakhijabir papaverineenhancestheoncolyticeffectsofnewcastlediseasevirusonbreastcancerinvitroandinvivo